Cargando…
Development and Validation of a Nomogram to Predict the 180-Day Readmission Risk for Chronic Heart Failure: A Multicenter Prospective Study
Background: The existing prediction models lack the generalized applicability for chronic heart failure (CHF) readmission. We aimed to develop and validate a widely applicable nomogram for the prediction of 180-day readmission to the patients. Methods: We prospectively enrolled 2,980 consecutive pat...
Autores principales: | Gao, Shanshan, Yin, Gang, Xia, Qing, Wu, Guihai, Zhu, Jinxiu, Lu, Nan, Yan, Jingyi, Tan, Xuerui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452908/ https://www.ncbi.nlm.nih.gov/pubmed/34557533 http://dx.doi.org/10.3389/fcvm.2021.731730 |
Ejemplares similares
-
Fibroblast Growth Factor 21 Predicts Short-Term Prognosis in Patients With Acute Heart Failure: A Prospective Cohort Study
por: Wu, Guihai, et al.
Publicado: (2022) -
Arterial Stiffness, Subendocardial Impairment, and 30-Day Readmission in Heart Failure Older Patients
por: Fantin, Francesco, et al.
Publicado: (2022) -
The Value of Admission Serological Indicators for Predicting 28-Day Mortality in Intensive Care Patients With Acute Heart Failure: Construction and Validation of a Nomogram
por: Wei, Xiaoyuan, et al.
Publicado: (2021) -
Establishment and Validation of a Non-invasive Diagnostic Nomogram to Identify Heart Failure in Patients With Coronary Heart Disease
por: Tan, Juntao, et al.
Publicado: (2022) -
Determining 30-day readmission risk for heart failure patients: the Readmission After Heart Failure scale
por: Chamberlain, Ronald S, et al.
Publicado: (2018)